Cargando…
A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
Aberrant splicing is frequently found in cancer, yet the biological consequences of such alterations are mostly undefined. Here we report that the Hippo–YAP signalling, a key pathway that regulates cell proliferation and organ size, is under control of a splicing switch. We show that TEAD4, the tran...
Autores principales: | Qi, Yangfan, Yu, Jing, Han, Wei, Fan, Xiaojuan, Qian, Haili, Wei, Huanhuan, Tsai, Yi-hsuan S., Zhao, Jinyao, Zhang, Wenjing, Liu, Quentin, Meng, Songshu, Wang, Yang, Wang, Zefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909989/ https://www.ncbi.nlm.nih.gov/pubmed/27291620 http://dx.doi.org/10.1038/ncomms11840 |
Ejemplares similares
-
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022) -
Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022) -
RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling
por: Choi, Sunkyung, et al.
Publicado: (2022) -
The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023) -
Gatekeepers of pancreas: TEAD and YAP
por: Rodríguez-Seguí, Santiago A., et al.
Publicado: (2015)